Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/2/25 16:34 | 12/1/25 | LQDA | Health | Drug | Pharmaceutical Preparations | Schundler Russell | NC | O | GC | 2 | S.d | -218 | 24.47 | 0 | -9 | 592 | D | |||||||||||||||
12/2/25 16:33 | 12/1/25 | LQDA | Health | Drug | Pharmaceutical Preparations | Krepp Sarah | NC | O | Chief Hu | 2 | S | -47 | 24.42 | 0 | -2 | 141 | D | |||||||||||||||
12/2/25 16:32 | 12/1/25 | LQDA | Health | Drug | Pharmaceutical Preparations | Kaseta Michael | NC | O | CFO,COO | 2 | S.d | -310 | 24.21 | 0 | -13 | 354 | D | |||||||||||||||
12/2/25 16:31 | 12/1/25 | LQDA | Health | Drug | Pharmaceutical Preparations | Boyle Dana | NC | O | Chief Ac | 4 | S | -791 | 25.02 | 0 | -32 | 185 | D | |||||||||||||||
12/2/25 16:31 | 12/1/25 | LQDA | Health | Drug | Pharmaceutical Preparations | Adair Jason | NC | O | Chief Bu | 4 | S.d | -1,195 | 29.35 | 0 | -41 | 176 | D | |||||||||||||||
12/2/25 16:30 | 12/1/25 | LQDA | Health | Drug | Pharmaceutical Preparations | Moomaw Scott | NC | O | Chief Co | 2 | S.d | -141 | 24.68 | 0 | -6 | 155 | D | |||||||||||||||
11/7/25 16:30 | 11/5/25 | LQDA | Health | Drug | Pharmaceutical Preparations | Saggar Rajeev | NC | O | Chief Me | 2 | S.d | -2,052 | 26.75 | 0 | -77 | 248 | D | |||||||||||||||
10/15/25 16:31 | 10/13/25 | LQDA | Health | Drug | Pharmaceutical Preparations | Jeffs Roger | NC | DO | CEO | 1 | S.d | -474 | 23.41 | 0 | -20 | 2,621 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |